Athersys, Inc. (ATHX): Price and Financial Metrics


Athersys, Inc. (ATHX)

Today's Latest Price: $2.01 USD

0.02 (-0.99%)

Updated Sep 30 11:59am

Add ATHX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 376 in Biotech

See all "A" rated Strong Buy stocks

ATHX Stock Summary

  • For ATHX, its debt to operating expenses ratio is greater than that reported by only 0.34% of US equities we're observing.
  • With a price/sales ratio of 40,072.92, Athersys Inc has a higher such ratio than 100% of stocks in our set.
  • As for revenue growth, note that ATHX's revenue has grown -99.9% over the past 12 months; that beats the revenue growth of only 0.47% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Athersys Inc are GENE, TGTX, CYAD, TRVN, and NK.
  • ATHX's SEC filings can be seen here. And to visit Athersys Inc's official web site, go to www.athersys.com.
ATHX Daily Price Range
ATHX 52-Week Price Range

ATHX Stock Price Chart Technical Analysis Charts


ATHX Price/Volume Stats

Current price $2.01 52-week high $4.38
Prev. close $2.03 52-week low $1.13
Day low $1.97 Volume 366,755
Day high $2.08 Avg. volume 3,314,464
50-day MA $2.31 Dividend yield N/A
200-day MA $2.15 Market Cap 396.78M

Athersys, Inc. (ATHX) Company Bio


Athersys, Inc. focuses on the research and development activities in the field of regenerative medicine. The company was founded in 1995 and is based in Cleveland, Ohio.


ATHX Latest News Stream


Event/Time News Detail
Loading, please wait...

ATHX Latest Social Stream


Loading social stream, please wait...

View Full ATHX Social Stream

Latest ATHX News From Around the Web

Below are the latest news stories about Athersys Inc that investors may wish to consider to help them evaluate ATHX as an investment opportunity.

Athersys: Still An Abundance Of Opportunity

In my last Seeking Alpha article Athersys: Abundance of Opportunity, I gave an overview of the company, highlighted the late-stage programs under development, and offered my views on potential upcoming catalysts. The four months since the publishing of that article has seen an unfortunate ramping up of a worldwide pandemic,...

Brian Schrank on Seeking Alpha | September 1, 2020

Athersys reports Q2 results, updates on BARDA collaboration

During the Q2 conference call, Athersys ([[ATHX]] -8.1%) provided an update on the status of its interactions with the Biomedical Advanced Research and Development Authority ((BARDA)) regarding a potential collaboration for its MultiStem as a therapy for patients experiencing acute respiratory distress syndrome ((ARDS)) due to COVID-19.The company said that in early...

Seeking Alpha | August 11, 2020

Athersys Reports Second Quarter 2020 Results

CLEVELAND--(BUSINESS WIRE)---- $ATHX #Athersys--Athersys has made progress during Q2 in key clinical programs and infrastructure to support its planned transition to becoming a commercial company.

Business Wire | August 10, 2020

Athersys to Host Second Quarter Financial Results Call

CLEVELAND--(BUSINESS WIRE)---- $ATHX #Athersys--Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2020 financial results on Monday, August 10, 2020.

Business Wire | July 20, 2020

Benzinga's Top Upgrades, Downgrades For June 25, 2020

Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The stock has a 52-week-high of $125.92 and a 52-week-low of $64.13. Allstate's stock last closed at $92.96 per share. * SunTrust Robinson Humphrey upgraded the stock for Diamondback Energy Inc (NASDAQ: FANG) from Hold to Buy. For the first quarter, Diamondback Energy had an EPS of $1.45, compared to year-ago quarter EPS of $1.39. The stock has a 52-week-high of $111.84 and a 52-week-low of $14.55. Diamondback Energy's stock last closed at $41.90 per share. * Goldman Sachs changed the rating for Ameriprise Financial Inc (NYSE: AMP) from Neutral to Buy. For the first quarter, Ameriprise F...

Yahoo | June 25, 2020

Read More 'ATHX' Stories Here

ATHX Price Returns

1-mo -7.80%
3-mo -24.72%
6-mo -30.21%
1-year 53.44%
3-year -2.43%
5-year 86.11%
YTD 63.41%
2019 -14.58%
2018 -20.44%
2017 18.30%
2016 48.54%
2015 -34.81%

Continue Researching ATHX

Here are a few links from around the web to help you further your research on Athersys Inc's stock as an investment opportunity:

Athersys Inc (ATHX) Stock Price | Nasdaq
Athersys Inc (ATHX) Stock Quote, History and News - Yahoo Finance
Athersys Inc (ATHX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7272 seconds.